MAP2K1 and melanoma: Patient Pt9 had a high frequency MEK1 variant (c.173A>C, p.Q58P, Table S3) located in a conserved region where several alterations have been reported in BRAFi-resistant melanoma samples [39] indicating that, this region might be involved in resistance but functional tests are required.